1059697-82-3 Usage
Uses
Used in Pharmaceutical Industry:
(S)-1-(benzo[d]thiazol-2-yl)ethan-1-ol is used as a therapeutic agent for the treatment of cardiovascular diseases such as pulmonary arterial hypertension, coronary artery disease, and thrombosis. Its vasodilatory effects and inhibition of platelet aggregation contribute to its potential in managing these conditions effectively.
Additionally, ongoing research and studies are exploring the full potential of (S)-1-(benzo[d]thiazol-2-yl)ethan-1-ol as a therapeutic agent, which may lead to further applications in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 1059697-82-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,9,6,9 and 7 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1059697-82:
(9*1)+(8*0)+(7*5)+(6*9)+(5*6)+(4*9)+(3*7)+(2*8)+(1*2)=203
203 % 10 = 3
So 1059697-82-3 is a valid CAS Registry Number.
1059697-82-3Relevant academic research and scientific papers
Kinetic resolution of racemic 1-heteroarylalkanols by asymmetric esterification using diphenylacetic acid with pivalic anhydride and a chiral acyl-transfer catalyst
Shiina, Isamu,Ono, Keisuke,Nakata, Kenya
supporting information; experimental part, p. 147 - 149 (2011/04/14)
A variety of optically active 1-heteroarylalkanols and their esters, which include heteroaromatic moieties, such as 2-furyl, 2-thienyl, 3-thienyl, 2-thiazoyl, 2-benzothiazoyl, and 2-benzoxazoyl groups, are efficiently produced by a novel asymmetric esterification. The transition states that form the desired (R)- esters from the (R)-1-heteroarylalkanols are determined by DFT calculations, and the structural features of these transition states are systematically discussed.
